ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2022

First Nations Persons Have an Increased Risk of Developing Rheumatoid Arthritis with an Early Onset Age but Are Seen Less Frequently By Rheumatologists: A Population Based Study

Carol A. Hitchon1, Sazzadul Khan2, Brenda Elias3, Hani S. El-Gabalawy4, Alan Katz5 and Christine A. Peschken1, 1Rheumatology, University of Manitoba, Winnipeg, MB, Canada, 2Manitoba Centre for Health Policy and Research, University of Manitoba, Winnipeg, MB, Canada, 3Department of Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada, 4Arthritis Centre, University of Manitoba, Winnipeg, MB, Canada, 5University of Manitoba, Winnipeg, MB, Canada

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Epidemiologic methods, health disparities and rheumatoid arthritis (RA), Native Americans

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Public Health (ACR): Rheumatoid Arthritis Pathogenesis and Treatment

Session Type: Abstract Submissions (ACR)

Background/Purpose  High global prevalence rates of rheumatoid arthritis (RA) have been reported in First Nations (FN).  For our regional population of 1.2 million, health care is universally covered, and health services and diagnoses based on International Classification of Disease codes (ICD-9CM) are recorded in the Population Health Research Database (PHRD) from 1984. As a first step to addressing RA care in FN, we validated case definitions for RA for use with the PHRD and described the incidence, prevalence, and health care use for RA.

Methods Records from April 1, 1995 to March 31, 2010 were accessed.  FN people were identified using linkage with the Federal Indian Registry File (FIRF) which records all registered FN for the purposes of entitlement.  Identification was expanded to include non-status Indians otherwise eligible (Metis, Inuit). Residents who resided in the province for ≥2 years were identified as having RA if they had ≥5 physician visits or hospitalizations with (ICD)-9-CM/ICD-10 codes 714/M05, M06 recorded. Persons resident for <2 years were identified as having RA if they had ≥3 such claims. This definition was validated for the years 2000-2010 by linkage with the Arthritis Centre database (includes self-identified nonFN, FN, Metis; RA n=2281; nonRA n=7044; definition sensitivity 77.12, specificity 90.30 Youden statistic 67.42).  Crude and age standardized prevalence rates for FN and nonFN in 2000-2010 were determined.  Onset age, (age at first RA code), was compared in prevalent cases.  Using a 5 year run-in time to eliminate prevalent cases, incident RA cases were identified and compared between FN and non-FN using logistic regression and odds ratios with 95% CI reported.  Physician visits and hospitalizations were compared between FN and nonFN from 2000-2010.

Results While both crude and age standardized overall prevalence rates of RA increased from 2000-2010 (crude prevalence 0.34% to 0.65%), FN had higher rates than nonFN in each year. In 2009-2010, crude rates were 0.85% vs. 0.63% for FN vs. nonFN, while age adjusted rates were 1.0% vs. 0.4%; for a rate that was 2.48 times higher in FN than non-FN in 2009-2010 (95%CI 2.471-2.472; p<0.0001).  The age standardized annual incidence of RA decreased from 0.07% in 2000 to 0.02% in 2010. The overall incidence of RA was higher in FN than nonFN at most years with FN having 2.23 times higher incidence of RA in 2009-2010 (CI 2.22-2.23; p<0.0001).  RA onset age was earlier in FN than non-FN (41 vs. 55 years; p<0.001).  Despite greater physician visits (110 vs 99; p<0.0001) (all rates are per person over 10 years) and more hospitalizations (3.4 vs 1.9 p<0.0001), FN had fewer rheumatologist visits (6.9 vs 8.2 p<0.0001), non-rheumatology specialist visits (15 vs 23 p<0.0001) and surgeries (3.7 vs 5.3 p<0.0001) than non FN.

Conclusion While overall provincial RA incidence is decreasing, FN have more than twice the risk of developing RA, with a prevalence of 1% in 2009-2010, as well as an onset age 10 years earlier than the general population.  When combined with generally more severe disease in FN and fewer rheumatology visits this demonstrates a significant care gap highlighting the need to optimize rheumatology care delivery to this population, particularly in view of the rapid growth of this population.


Disclosure:

C. A. Hitchon,
None;

S. Khan,
None;

B. Elias,
None;

H. S. El-Gabalawy,
None;

A. Katz,
None;

C. A. Peschken,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/first-nations-persons-have-an-increased-risk-of-developing-rheumatoid-arthritis-with-an-early-onset-age-but-are-seen-less-frequently-by-rheumatologists-a-population-based-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology